Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DermNet is a New Zealand-based, not-for-profit dermatology publisher and online clinical resource focused on evidence-based information about skin diseases, conditions, procedures, and treatments. It operates one of the world’s leading free dermatology websites, serving healthcare professionals and the public with a large educational content library and more than 20,000 dermatology images. The organization was launched in 1996 by dermatologists Amanda Oakley, Mark Duffill, and Marius Rademaker, and is owned by the New Zealand Dermatological Society. DermNet’s business model appears to center on digital health publishing, education, image licensing, and related sponsorship/advertising rather than drug development. It is healthcare-related, but it is not a biotech or pharmaceutical company and does not appear to maintain a therapeutic development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DermNet.